Peer-Reviewed Publications Resulting from CHF-funded Grants
We invite you to learn about publications resulting from the Foundation's investments in research. One way CHF measures success in grantmaking is through the production of peer-reviewed publications. CHF-supported research has been published in 218 different peer-reviewed journals, including Nature Genetics and Science and frequently in journals such as the Journal of Veterinary Internal Medicine, Animal Genetics and the American Journal of Veterinary Research. By consistently funding the most innovative research, the AKC Canine Health Foundation is realizing both small milestones and major breakthroughs in canine health.
You may search the complete list of peer-reviewed publications by research program area, breed and/or disease associated with the grant.
To browse publications by year you may also wish to view our Impact Report.
|
Grant Number: 03313-A Research Program Area: Immunology and Infectious Disease |
Standardization and Evaluation of the Use of LPG3 Linear Peptides Alone or in Chimera Form for the Serodiagnosis of CVL by ELISA None at this time. |
|
Grant Number: 03305-A Research Program Area: Oncology |
TRAF3 as a Novel Prognostic Biomarker in Canine Tumor-associated Macrophages None at this time. |
|
Grant Number: 1137 Research Program Area: Ophthalmology |
Eradication of Cairn Terrier Ocular Melanosis None at this time. |
|
Grant Number: 03019 Research Program Area: Oncology - Osteosarcoma, Oncology |
Evaluation of a Targeted Anti αvβ3 Integrin Near-InfraRed (NIR-) Dye for Controlled Resection of Naturally Occurring Soft Tissue Sarcomas in Dogs
Erin Beebe, Amiskwia Pöschel, Laura Kunz, Witold Wolski, Zahra Motamed, Daniela Meier, Franco Guscetti, Mirja C. Nolff, Enni Markkanen, Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue, Neoplasia, Volume 35, 2023, 100858, ISSN 1476-5586, https://doi.org/10.1016/j.neo.2022.100858 |
|
Grant Number: 01355-A Research Program Area: Oncology - Hemangiosarcoma |
Expression of Vascular Endothelial markers in Canine Hemangiosarcoma and their use in Diagnostic Cytology Using Immunocytochemistry None at this time. |
|
Grant Number: 02825-A Research Program Area: Dermatology and Allergic Disease |
Effect(s) of Atopic Dermatitis-associated Cytokines on Staphylococcus pseudintermedius None at this time. |
|
Grant Number: 00845-A Research Program Area: Blood Disorders |
Platelet Surface Glycoprotein Function in Related and Unrelated Newfoundland Dogs None at this time. |
|
Grant Number: 03011 Research Program Area: Oncology - Hemangiosarcoma |
A GD3 Nano-scaled Liposomal Cancer Vaccine Clinical Trial for Canine Hemangiosarcoma Faroni E, Sabattini S, Guerra D, Iannuzzi C, Chalfon C, Agnoli C, Stefanello D, Polton G, Ramos S, Aralla M, Ciaccini R, Foglia A, Okonji S, Marconato L. Timely adjuvant chemotherapy improves outcome in dogs with non-metastatic splenic hemangiosarcoma undergoing splenectomy. Vet Comp Oncol. 2023 Mar;21(1):123-130. doi: 10.1111/vco.12875. Epub 2023 Jan 21. PMID: 36633399. |
|
Grant Number: 03293 Research Program Area: Oncology - Osteosarcoma |
Foundational Studies for Translating FGFR Inhibition in Canine Osteosarcoma None at this time. |
|
Grant Number: 02244-A Research Program Area: Oncology |
Beyond Peto's Paradox with the Geriatric Peromyscus None at this time. |
|
Grant Number: 1301 Research Program Area: Kidney & Urological Disease |
Development of DNA Markers for Shar-Pei Fever None at this time. |
|
Grant Number: 01185-A Research Program Area: Blood Disorders |
Hemophilia A in Golden Retrievers - Search for the Causative Mutation None at this time. |
|
Grant Number: 975 Research Program Area: Immunology and Infectious Disease |
Characterization and Modulation of Canine Mast Cell Derived Eicosanoids Lin, T.-Y., & London, C. A. (2010). Characterization and modulation of canine mast cell derived eicosanoids. Veterinary Immunology and Immunopathology, 135(1–2), 118–127. https://doi.org/10.1016/j.vetimm.2009.11.010 |
|
Grant Number: 02323 Research Program Area: Epilepsy Initiative |
Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy Hartsel, J. A., Boyar, K., Pham, A., Silver, R. J., & Makriyannis, A. (2019). Cannabis in Veterinary Medicine: Cannabinoid Therapies for Animals: Clinical Efficacy of CBD for Treating Osteoarthritis and Refractory Epilepsy in the Dog: A Pilot Study. In R. C. Gupta, A. Srivastava, & R. Lall (Eds.), Nutraceuticals in Veterinary Medicine (pp. 121–155). https://doi.org/10.1007/978-3-030-04624-8_10
Rozental AJ, Weisbeck BG, Corsato Alvarenga I, et al. The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study. Journal of Veterinary Internal Medicine. 2023;37(6):2291-2300. doi:10.1111/jvim.16912 |
|
Grant Number: 01857-A Research Program Area: Immunology and Infectious Disease |
Decreasing the Mortality Rate of Shock through Enhanced Monitoring of Tissue Oxygen Levels None at this time. |
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
